RHH-001 Phase IV Trial

New AstraZeneca COVID-19 vaccine data further support its use as third dose booster

Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that AstraZeneca COVID-19 vaccine (ChAdOx1-S…